<p>PBMC derived from RRMS patients (n = 9) were stimulated with 1α,25 Dihydroxyvitamin D3 (100 nM) and/or IFN beta (1000 IE) over a 48 h period. ILT3 and ILT4 protein expression on CD14+ cells was assessed by flow cytometry. The fold induction is shown (mean + SEM). A repeated measurement ANOVA with Bonferroni multiple comparison test was performed to assess statistical significance (* p<0,05; **p<0.005).</p
<p>The upper panels are representative images of individual experiments. (<b>A</b>) Bar graphs show ...
<p><b>A, B</b>) Vδ2<sup>+</sup>CD3<sup>+</sup> cell fold increases in LR (n = 16) and R (n = 32) EOC...
Background. The active metabolite of vitamin D3-1,25(OH)2D3-is a well-known differentiation inducer....
<p>(A) The baseline expression of the immune inhibitory receptors ILT3 and ILT4 on peripheral blood ...
<p>Relative expression of ILT3 mRNA in PBMC derived from IFN beta treated patients with RRMS (n = 10...
<p>(A) Flow cytometry for HGF was performed on CD14<sup>+</sup> monocytes from the three groups (hea...
<p>(A) CD100 expression on CD5+ and CD5- B cells from one representative, healthy donor before and a...
<p>PBMC were incubated for 12h with medium or 10 ng/mL LPS, washed, and treated with medium or 100 n...
<p>Monocyte-derived DCs from healthy individuals were generated without (control) or with a combinat...
<p>Human PBMCs (n = 3) were isolated from healthy subjects and pre-incubated with 1,25(OH)<sub>2</su...
<p>(A) Comparison of the ability of healthy donors and CHB patients to produce IFN-α. PBMCs (2×10<su...
<p>(A) Expression of miR-422a in PBMC <i>in vivo</i> before, during and after IFN-α/RBV treatment (l...
<p>Human PBMCs or T cells were treated with IFN–β for the indicated time and dose. Culture supernata...
<p>Male or female CD4<sup>+</sup> T cells (2 x 10<sup>5</sup> cells/well) and CD11c<sup>+</sup> cell...
A/B. Comparison between CHB, NC and AHB groups of effector functions in circulating γδT-cell subsets...
<p>The upper panels are representative images of individual experiments. (<b>A</b>) Bar graphs show ...
<p><b>A, B</b>) Vδ2<sup>+</sup>CD3<sup>+</sup> cell fold increases in LR (n = 16) and R (n = 32) EOC...
Background. The active metabolite of vitamin D3-1,25(OH)2D3-is a well-known differentiation inducer....
<p>(A) The baseline expression of the immune inhibitory receptors ILT3 and ILT4 on peripheral blood ...
<p>Relative expression of ILT3 mRNA in PBMC derived from IFN beta treated patients with RRMS (n = 10...
<p>(A) Flow cytometry for HGF was performed on CD14<sup>+</sup> monocytes from the three groups (hea...
<p>(A) CD100 expression on CD5+ and CD5- B cells from one representative, healthy donor before and a...
<p>PBMC were incubated for 12h with medium or 10 ng/mL LPS, washed, and treated with medium or 100 n...
<p>Monocyte-derived DCs from healthy individuals were generated without (control) or with a combinat...
<p>Human PBMCs (n = 3) were isolated from healthy subjects and pre-incubated with 1,25(OH)<sub>2</su...
<p>(A) Comparison of the ability of healthy donors and CHB patients to produce IFN-α. PBMCs (2×10<su...
<p>(A) Expression of miR-422a in PBMC <i>in vivo</i> before, during and after IFN-α/RBV treatment (l...
<p>Human PBMCs or T cells were treated with IFN–β for the indicated time and dose. Culture supernata...
<p>Male or female CD4<sup>+</sup> T cells (2 x 10<sup>5</sup> cells/well) and CD11c<sup>+</sup> cell...
A/B. Comparison between CHB, NC and AHB groups of effector functions in circulating γδT-cell subsets...
<p>The upper panels are representative images of individual experiments. (<b>A</b>) Bar graphs show ...
<p><b>A, B</b>) Vδ2<sup>+</sup>CD3<sup>+</sup> cell fold increases in LR (n = 16) and R (n = 32) EOC...
Background. The active metabolite of vitamin D3-1,25(OH)2D3-is a well-known differentiation inducer....